Long-Term Cardiovascular Benefits Associated With Sodium-Glucose Cotransporter 2 Inhibitors
SGLT2 inhibitors were associated with a decreased risk for acute kidney injury, but researchers observed an increased risk for urinary tract infections.
The approval of Retacrit was based on a review of evidence that included human pharmacokinetic/pharmacodynamic data and clinical immunogenicity data which demonstrated a high degree of similarity between Retacrit and ...
An annual wellness exam performed by an OB/GYN can be used to evaluate a woman's heart health.
Investigators examined 6 biomarkers for predicting adverse cardiovascular outcomes in patients with type 2 diabetes.